EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) shares were up 50,683,960.6% during mid-day trading on Thursday . The company traded as high as $0.40 and last traded at $214,748.36. Approximately 20,000 shares were traded during trading, a decline of 8% from the average daily volume of 21,810 shares. The stock had previously closed at $0.42.
EKF Diagnostics Trading Up 50,683,960.6%
The business’s 50-day simple moving average is $4,295.36 and its 200-day simple moving average is $1,481.36.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- There Are Different Types of Stock To Invest In
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
